Ligand Pharmaceuticals (LGND) News Today $103.18 -3.18 (-2.99%) As of 02:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Dimensional Fund Advisors LP Buys 16,003 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Dimensional Fund Advisors LP lifted its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 2.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 723,019 shares of the biotechnology company's stockMay 3 at 4:02 AM | marketbeat.comLigand Pharmaceuticals (LGND) Projected to Post Earnings on ThursdayLigand Pharmaceuticals (NASDAQ:LGND) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-ligand-pharmaceuticals-incorporated-stock/)May 3 at 2:14 AM | marketbeat.comRaymond James Financial Inc. Makes New Investment in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Raymond James Financial Inc. bought a new position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 21,830 shares of the biotechnology company's stock, valued at approximatMay 2, 2025 | marketbeat.comLigand to Participate in May Investor ConferencesMay 1, 2025 | globenewswire.comLigand Pharmaceuticals (LGND) Expected to Announce Quarterly Earnings on ThursdayMay 1, 2025 | americanbankingnews.comIs Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Trading At A 49% Discount?April 30, 2025 | finance.yahoo.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Acquired by Wells Fargo & Company MNWells Fargo & Company MN boosted its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 29.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,220 shaApril 30, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Sold by Barclays PLCBarclays PLC cut its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 8.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,972 shares of the bApril 29, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Position Boosted by Penn Capital Management Company LLCPenn Capital Management Company LLC lifted its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 4.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 104,430 shares of the bApril 26, 2025 | marketbeat.comXTX Topco Ltd Takes Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)XTX Topco Ltd purchased a new position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,067 shares of the biApril 26, 2025 | marketbeat.comLigand to Report First Quarter 2025 Financial Results on May 8, 2025April 24, 2025 | globenewswire.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Acquired by Uniplan Investment Counsel Inc.Uniplan Investment Counsel Inc. increased its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 28.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 68,155 shares of the biotechApril 24, 2025 | marketbeat.comLGND: Pelthos To Become Public CompanyApril 23, 2025 | msn.comJPMorgan Chase & Co. Has $4.05 Million Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)JPMorgan Chase & Co. decreased its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 33.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 37,761 shares of the biotechnoApril 22, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Average Rating of "Buy" by AnalystsLigand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) has earned an average rating of "Buy" from the seven research firms that are presently covering the firm, Marketbeat reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price target amApril 22, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Purchased by Invesco Ltd.Invesco Ltd. boosted its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 3.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 194,355 shares of theApril 21, 2025 | marketbeat.comRevisiting Ligand Pharmaceuticals, Ready To Accumulate If Shares Dip Below $100April 20, 2025 | seekingalpha.comNFJ Investment Group LLC Purchases New Shares in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)NFJ Investment Group LLC acquired a new position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 11,847 shares of the biotechnologyApril 20, 2025 | marketbeat.comLigand Pharmaceuticals: Ligand Subsidiary Pelthos Therapeutics to Combine with Channel TherapeuticsApril 18, 2025 | finanznachrichten.deChannel Therapeutics Stock Soars On Announcement Of Subsidiary’s Merger With Ligand Pharma Units: Retail’s ElatedApril 18, 2025 | msn.comLigand Pharmaceuticals (LGND) and Channel Therapeutics Announce Merger to Form Pelthos ...April 17, 2025 | gurufocus.comLigand Subsidiary Pelthos Therapeutics to Combine with Channel TherapeuticsApril 17, 2025 | globenewswire.comTownsquare Capital LLC Purchases 4,726 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Townsquare Capital LLC raised its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 15.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,539 shares of the biotechnology company's stockApril 17, 2025 | marketbeat.comGeode Capital Management LLC Buys 10,171 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Geode Capital Management LLC increased its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 438,441 shares of theApril 16, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Upgraded at StockNews.comStockNews.com raised shares of Ligand Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Tuesday.April 16, 2025 | marketbeat.comJ&J kicks off pharma earnings season with guidance raise amid looming tariffsApril 15, 2025 | msn.comGranite Investment Partners LLC Sells 2,463 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Granite Investment Partners LLC reduced its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 2.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 115,538 shares of the biotechnology company's stock after seApril 15, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Sold by Russell Investments Group Ltd.Russell Investments Group Ltd. reduced its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 17.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 95,600 shares of the biotechnology company's stockApril 14, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Earns Buy Rating from Analysts at Stifel NicolausStifel Nicolaus started coverage on Ligand Pharmaceuticals in a research report on Thursday. They set a "buy" rating and a $143.00 target price for the company.April 12, 2025 | marketbeat.comF M Investments LLC Cuts Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)F M Investments LLC reduced its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 60.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 52,883 shares of the biotechnologApril 12, 2025 | marketbeat.comCenterBook Partners LP Trims Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)CenterBook Partners LP lessened its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 53.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 23,539 shares of the biotechnologyApril 12, 2025 | marketbeat.comNorges Bank Makes New Investment in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Norges Bank purchased a new position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 46,290 shares of the biotechnology company's stock, valued at approximately $4,960,000. NoApril 12, 2025 | marketbeat.comLigand initiated with a Buy at StifelApril 11, 2025 | markets.businessinsider.comStifel Initiates Coverage of Ligand Pharmaceuticals (LGND) with Buy RecommendationApril 11, 2025 | msn.comThis Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayApril 10, 2025 | benzinga.comLigand Pharmaceuticals (NASDAQ:LGND) Cut to Sell at StockNews.comStockNews.com downgraded shares of Ligand Pharmaceuticals from a "hold" rating to a "sell" rating in a research report on Monday.April 9, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Takes Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Massachusetts Financial Services Co. MA bought a new position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 276,731 shares of the biotechnApril 8, 2025 | marketbeat.comFranklin Resources Inc. Purchases 90,743 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Franklin Resources Inc. boosted its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 95.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 185,402 shares of the biotechnology company's stock after buying an additiApril 8, 2025 | marketbeat.comVanguard Group Inc. Buys 115,005 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Vanguard Group Inc. increased its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 5.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,085,627 shares of the biotecApril 7, 2025 | marketbeat.com3,900 Shares in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Acquired by KLP Kapitalforvaltning ASKLP Kapitalforvaltning AS purchased a new stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 3,900 shares of the biotechnology company's sApril 6, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Short Interest UpdateLigand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 955,100 shares, an increase of 22.4% from the February 28th total of 780,100 shares. Based on an average daily trading volume, of 115,100 shares, the days-to-cover ratio is currently 8.3 days. Currently, 5.4% of the company's shares are sold short.April 4, 2025 | marketbeat.comRaymond James Financial Inc. Makes New $2.34 Million Investment in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Raymond James Financial Inc. acquired a new position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 21,830 shares of the biotechnologyMarch 30, 2025 | marketbeat.comLoomis Sayles & Co. L P Purchases 24,921 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Loomis Sayles & Co. L P raised its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 6.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 397,700 shares of the biotechnologMarch 29, 2025 | marketbeat.comVirtu Financial LLC Takes $338,000 Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Virtu Financial LLC acquired a new position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 3,155 shares of the biotechnology coMarch 29, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Recommendation of "Buy" from AnalystsShares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) have been given a consensus recommendation of "Buy" by the six ratings firms that are covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1-year priceMarch 27, 2025 | marketbeat.comCongress Wealth Management LLC DE Purchases 4,014 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Congress Wealth Management LLC DE lifted its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 4.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 94,335 sharMarch 25, 2025 | marketbeat.com4,418 Shares in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Purchased by Summit Global InvestmentsSummit Global Investments acquired a new stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 4,418 shares of the biotechnology companMarch 25, 2025 | marketbeat.comRoyce & Associates LP Sells 3,193 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Royce & Associates LP trimmed its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 52.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,897 shares of the biotechnology company's stock afterMarch 23, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Increases Stock Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Charles Schwab Investment Management Inc. boosted its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 4.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 170,419March 20, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Sells 3,200 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)Connor Clark & Lunn Investment Management Ltd. reduced its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 11.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 23,763 sharesMarch 19, 2025 | marketbeat.com Get Ligand Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LGND and its competitors with MarketBeat's FREE daily newsletter. Email Address LGND Media Mentions By Week LGND Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LGND News Sentiment▼0.930.69▲Average Medical News Sentiment LGND News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LGND Articles This Week▼76▲LGND Articles Average Week Get Ligand Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LGND and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RGEN News Today HALO News Today MDGL News Today IONS News Today ALKS News Today FOLD News Today BCRX News Today MNKD News Today CLDX News Today DVAX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LGND) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredConfidential Economic AdvisoryI've hesitated for months to record this video. The very act of sharing these details makes me deeply uncom...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ligand Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Ligand Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LGND Stock Free LGND Stock Alerts